Shopping Cart
- Remove All
- Your shopping cart is currently empty
Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $119 | In Stock | |
5 mg | $287 | In Stock | |
10 mg | $456 | In Stock | |
25 mg | $749 | In Stock | |
50 mg | $1,060 | In Stock | |
100 mg | $1,420 | In Stock | |
500 mg | $2,850 | In Stock |
Description | Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer. |
Alias | BEY1107, Avotaciclib |
Molecular Weight | 281.27 |
Formula | C13H11N7O |
Cas No. | 1983983-41-0 |
Smiles | OC1=C(N=C(C=C1)C2=NC(N)=NC=C2)C3=NC(N)=NC=C3 |
Relative Density. | 1.487 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (177.77 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.